FEMASYS INC cotiza a 1.76 USD y tiene una capitalización bursátil de $15M. En los últimos 12 meses ha facturado $2M con un margen de flujo de caja libre del -837.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultraso…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-1.46 | $-0.20 | $-2.00 | $-3.20 |
| Estimado | $-1.80 | $-1.80 | $-2.60 | $-3.60 |
| Sorpresa | +18.9% | +88.9% | +23.1% | +11.1% |
| Métrica | FEMY | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 62.0% | 57.0% | +4.9% |
| Operating Margin | -767.0% | -38.6% | -728.3% |
| Net Margin | -812.3% | -33.6% | -778.7% |
| FCF Margin | -837.9% | -13.9% | -824.0% |
| ROE | -317.4% | -40.4% | -277.0% |
| ROA | -89.9% | -32.0% | -57.9% |
| Current Ratio | 4.53 | 2.84 | +1.69 |
| Debt / Equity | — | 0.28 | — |